Evan S Leibu, MD

Clinical Focus

• Anxiety
• Bipolar Disorder
• Depression
• Mental Health Services
• Obsessive-Compulsive Disorder
• Schizophrenia
• Stress Management/Anxiety Disorders

• Anxiety
• Bipolar Disorder
• Depression
• Mental Health Services
• Obsessive-Compulsive Disorder
• Schizophrenia
• Stress Management/Anxiety Disorders

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Article:12

Letter:1

Recent Artifacts

• Baseline brain structural and functional predictors of clinical outcome in the early course of schizophrenia
• Depth-dependent intracortical myelin organization in the living human brain determined by in vivo ultra-high field magnetic resonance imaging
• High-dose ondansetron reduces activation of interoceptive and sensorimotor brain regions
• Resting-state network connectivity and metastability predict clinical symptoms in schizophrenia
• Multivariate associations among behavioral, clinical, and multimodal imaging phenotypes in patients with psychosis
• Neural correlates of interoception: Effects of interoceptive focus and relationship to dimensional measures of body awareness
• Neural correlates of affective and non-affective cognition in obsessive compulsive disorder: A meta-analysis of functional imaging studies
• Addressing reverse inference in psychiatric neuroimaging: Meta-analyses of task-related brain activation in common mental disorders
• Safety and efficacy of electroconvulsive therapy for depression in the presence of deep brain stimulation in obsessive-compulsive disorder
• Electroconvulsive therapy (ECT) for catatonia in a patient with schizophrenia and synthetic cannabinoid abuse: A case report

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Leibu did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.